Rendle Linda J reported grant involving 50,988 shares of CLOROX CO DE at $83.94 for $4.28M on Sep 23, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Chief Executive Officer
Chief Executive Officer
Filed Sep 25, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$4,279,932.72Shares × reported price
Shares traded
50,988Common Stock
Price per share
$83.94Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
252,149Direct
Trade date
Sep 23, 2026Grant
Filed
Sep 25, 2026, 5:17 PM ET2-day reporting delay
Accession
0001225208-26-007949Code A · Transaction 229919
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

CLX price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CLX · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +0.9%1w ago 0%1d ago 0%
Returns since7d −24%30d −19%90d180d1y

Footnotes in full

F1: The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2027, 2028, 2029, and 2030.